Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Key Findings on the Global Orthobiologics Market| Technavio

Technavio Research
Posted on: 11 Mar 18

Market research firm Technavio has announced the release of their newest report on the global orthobiologics market. This new report will provide expert market insights for the forecast period 2018-2022.

This press release features multimedia. View the full release here:

Technavio has published a new market research report on the global orthobiologics market from 2018-2022. (Graphic: Business Wire)

The report will present an updated analysis of the market with regards to the current competitive landscape and global environment. It will also provide an up-to-date analysis of the latest trends, drivers, and challenges.

The upgraded research report on the orthobiologics market is an integral part of Technavio’s orthopedics and medical devices portfolio. Technavio covers an extensive range of market research reports on the rapidly expanding orthopedics and medical devices sector. Some of the topics include GI stool testing market, hospital stretchers market, diabetic eye disease devices market, dental services market, and psoriatic arthritis market.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy2 reports and get the third for FREE: View all Technavio’s current offers

Global growth opportunities in the market

In Technavio’s previous report on the global orthobiologics market, the Americas dominated the market with 60% share over APAC and EMEA. North America was the highest contributor in the Americas. The increasing demand for these products to treat various orthopedic indications such as spinal injuries and osteoarthritis was the major driving factor in the region.

In the previous report, a senior research analyst at Technavio stated, “One of the primary drivers for the global orthobiologics market is the formation of strategic partnerships for marketing. Many players in the market are establishing strategic partnerships to expand their businesses, extend their product offerings, and increase their market shares. Such partnerships also help companies to align their technologies with each other's innovative medical device portfolio.”

Technavio’s new report on the global orthobiologics market will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions.

Looking for the latest information on the global orthobiologics market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Detailed analysis at your fingertips

Some of the topics that will be revisited in the new report include:

  • Market size growth through 2022
  • Top factors driving the market growth
  • Competitive landscape and market share analysis of the key players
  • Market opportunities and factors impeding growth

The report on the global orthobiologics market for the period 2018-2022 is available to order now and will be delivered within one week of purchase.


Technavio’s best deals of the month!


Celebrate Earth Day and clean energy with Technavio. Get 30% discounton all Energy reports. Offer valid from 12th March - 18th March.




Get 20% off on all Media and Entertainment Services reports. Offer valid only till the 31st of March.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at

View source version on

Business Wire

Last updated on: 11/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.